Dr O’Kennedy has over twenty years of experience in the biopharmaceutical sector having worked for large biopharmaceutical companies, CMOs and in academia.
CEO and Founder
Timothy Gardner is the Founder and the CEO of Riffyn – a cloud and scientific services company that has produced the world’s first scientific process data system.
Head of Cell Culture Plant
MSc Biotechnology background gained at University of Silesia in Katowice and Maria Skłodowska-Curie Memorial Cancer Center in Gliwice, Poland.
Market Development Manager
Experienced Market Development Manager with a demonstrated history of working in the biotechnology industry.
Head of Global Technology & Innovation Management
Samet is the Head of Global Technology & Innovation Management in the Boehringer Ingelheim Biopharma Business Unit.
Uwe Gottschalk is Chief Technology Officer (CTO) at Lonza Pharma/Biotech since June 2014.
Head of Biologicals Strategy
Dorothee joined the leadership team of Boehringer Ingelheim
Global Pilot Operations Leader
Francis Verhoeye serves as Global Pilot Operations Lead at Zoetis and is managing at the international level the Pilot Network specialized
Market Manager LifeScience
Academic Studies: University of Applied Sciences Berlin, Biotechnology
Full Professor, Chemical and Biochemical Engineering, Faculty of Sciences and Technology, Univ. Nova de Lisboa (1995-presently jubilated).
Senior Manager Operations Bioprocessing Technology
Rutger Douma holds an MSc from Wageningen University in Bioprocess Technology and obtained his PhD at Delft University of Technology on penicillin fermentations.
Marc Pompiati has over 19 years of experience in biotechnology process development, tech transfer and technology development.
Dr. Michael Sokolov is a chemical engineer by training and a Scientist at ETH Zurich, where he also holds a Lecturer position for statistics for chemical engineers.
Cell Culture Plant MS&T Manager
MSc in Biotechnology at Technical University of Lodz; 8 years of practical and theoretical experience in manufacturing of sterile and low bioburden monoclonal antibodies.
Reader in Biosystems Engineering
Cleo Kontoravdi's interests lie in the area of biotechnology.
Section Head Molecular Biology
Leonardo Magneschi obtained a Ph.D. in Plant and Microbial Biotechnology. After his Ph.D. he was awarded an Alexander von Humboldt postdoctoral fellowship to investigate biofuel production in algae.
Marketing and Market Development Manager
Dr. Stephen Lock obtained his PhD in Physical Organic Chemistry from the University College of Swansea in 1993 and is a chartered chemist and a member of the Royal Society of Chemistry.
President & CEO BI Fremont
Jens H. Vogel, Ph.D. is President and CEO of Boehringer Ingelheim Fremont Inc. Jens
Chief Scientific Officer
Louis Boon received his Ph.D. in Biochemistry at the University of Amsterdam.
Senior R&D Manager
We developed a combined process featuring N-1 perfusion in a novel expansion medium and high cell density cryopreservation (HCDC)
Field Application Engineer Life Sciences EMEA
Mr. Cartoux joined Entegris in January 2018 as an Application engineering team.
Senior Global Product Manager
Mark Lies is a Global Senior product Manager for Capillary Electrophoresis (CE).
Director, Gene Expression Strategies
Ph.D. in Cell Biology from Fordham University and Sloan Kettering Cancer Center in New York.Director and Principal Scientist at MacroGenics, Inc. (2002- present).
Elected a Fellow of the Royal Society of Chemistry and trained Chartered Chemist with 36 years of experience specialising
Principal Scientist, Particle Engineering
Main interests and professional experience include development of drying processes for biopharmaceuticals, small and large molecules, drug substance and product, excipients, scale-up.
VP, Head of Biological Development
Felix Oehme received his Ph.D. in Biochemistry at the University of Munich. He joined Bayer in 1999 and worked as a Head of Laboratory in cardiovascular and biologics research.
Head of High Throughput Bioprocess Development
Sebastian Hans leads the High Throughput Bioprocess Development Group at the Department of Bioprocess Engineering at the TU Berlin since 2019.
Head of Research Division Biochemical Engineering
Christoph Herwig, bioprocess engineer from RWTH Aachen, worked in industry in the design and commissioning of large chemical facilities prior to enter his interdisciplinary PhD studies at EPFL.
SVP and Global Head of Biotech
Experienced Senior Vice President of Pharmaceutical
Chief Operating Officer
He is heavily involved in the strategic orientation of our CDMO business.
Unit Head Cell Line Screening and Development
Zorica Dragic Arunasalam leads Cell Line Development team in Novartis Biologics Center
Chief Technology Officer
Dr. Jesse McCool has over 17 years’ experience in microbial process development, characterization and technology transfer.
Thomas Maischberger is a Process Engineer at ZETA GmbH (Austria) and has experience in industrial microbiology, enzyme technology, and bioprocess optimisation.
Associate Principal Scientist
Paolo Avalle is and Associate Principal Scientist working for Merck Sharp and Dohme (MSD) in Switzerland.